The use of minimally invasive glaucoma surgery in the U.S. increased twofold, with a gradual decrease in the use of standard procedures, from 2013 to 2018, according to the IRIS Registry.
“There was a significant increase in MIGS use over the recent 6-year period despite limited evidence of their long-term safety or effectiveness, highlighting the need for studies comparing safety and outcomes of novel MIGS vs. traditional surgical treatments for glaucoma,” Shuang-An Yang, MD, MPH, said at the virtual American Glaucoma Society annual meeting.
Yang and colleagues used the American
Uncategorized